1. World Health Organization (2022): Health Topics: Global Tuberculosis Report 2022. https://www.who.int/publications/m/item/global-tb-report-2022-advocacy-toolkit.
2.
ECDC (2020): Tuberculosis – Annual Epidemiological Report for 2020. European Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/publications-data/tuberculosis-annual-epidemiological-report-2020
3.
Bell LCK, Noursadeghi M (2018): Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nat Rev Microbiol 16: 80-90.
4.
SPKC (2020): Infekcijas slimības – statistika un pētījumi: Pārskati par atsevišķām infekcijas un parazitārajām slimībām. https://www.spkc.gov.lv/lv/media/15144/download?attachment
5.
SPKC (2021): Infekcijas slimības – statistika un pētījumi: Pārskati par atsevišķām infekcijas un parazitārajām slimībām. https://www.spkc.gov.lv/lv/media/17441/download?attachment
6.
Parslow TG, Stites DP, Terr AI, Imboden JB (2001): Medical Immunology. McGraw-Hill/Appleton & Lange.
7.
Bodis G, Toth V, Schwarting A (2018): Role of human leukocyte antigens (HLA) in autoimmune diseases. Rheumatol Ther 5: 5-20.
8.
Cai L, Li Z, Guan X, Cai K, et al. (2019): The Research Progress of Host Genes and Tuberculosis Susceptibility. Oxid Med Cell Longev 2019: 9273056.
9.
Anaya J, Shoenfeld Y, Rojas-Villarraga A, et al. (2013): Autoimmunity from Bench to Bedside. El Rosario University Press, Bogota.
10.
Tobin DM (2015): Host-directed therapies for tuberculosis. Cold Spring Harb Perspect Med 5: a021196.
11.
Walsh E, Sabeti P, Hutcheson H, et al. (2006): Searching for signals of evolutionary selection in 168 genes related to immune function. Hum Genet 119: 92-102.
12.
Apanius V, Penn D, Slev RP, et al. (2017): The nature of selection on the major histocompatibility complex. Crit Rev Immunol 37: 75-125.
13.
Blackwell JM, Jamieson S, Burgner D (2009): HLA and infectious diseases. Clin Microbiol Rev 22: 370-385.
14.
Laivacuma S, Eglīte J, Derovs A, Vīksna L (2019): Distribution of HLA allele frequencies in patients with cystic and alveolar echinococcosis in Latvia. Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences. Riga; 296-303. doi: https://doi.org/10.2478/prolas-2019-0047
15.
Stein MC, Sausville L, Wejse C, et al. (2017): Genomics of human pulmonary tuberculosis: from genes to pathways. Curr Genet Med Rep 5: 149-166.
16.
Kone A, Diarra B, Cohen K, et al. (2019): Differential HLA allele frequency in M. africanum vs. M. tuberculosis in Mali. HLA 93: 24-31.
17.
Murugesan H, Paramasivam S, Bethunaickan R (2018): Influence of genetic polymorphism towards pulmonary tuberculosis susceptibility. Front Med 5: 213.
18.
Kuranov A, Kozhamkulov U, Vavilov M, et al. (2014): HLA-class II alleles in patients with drug-resistant pulmonary tuberculosis in Kazakhstan. Tissue Antigens 83: 106-112.
19.
Kim H, Park M, Song E, et al. (2005): Association of HLA-DR and HLA-DQ genes with susceptibility to pulmonary tuberculosis in Koreans: Preliminary evidence of associations with drug resistance, disease severity, and disease recurrence. Hum Immunol 66: 1074-1081.
20.
Starshinova A, Korneva N, Dovgalyuk I, et al. (2015): Influence of HLA-DRB1* allelic sets on the development of tuberculosis in children. Med Immunol (Russia) 275. doi: 10.15789/1563-0625-2015-3-275-280
21.
Amirzargar A, Yalda A, Hajabolbaghi M, et al. (2004): The association of HLA-DRB, DQA1, DQB1 alleles and haplotype frequency in Iranian patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 8: 1017-1021.
22.
Dubaniewicz A, Moszkowska G, Szczerkowska Z (2005): Frequency of DRB1-DQB1 two-locus haplotypes in tuberculosis: preliminary report. Tuberculosis (Edinb) 85: 259-267.
23.
Ruggiero G, Cosentini E, Zanzi D, et al. (2004): Allelic distribution of human leucocyte antigen in historical and recently diagnosed tuberculosis patients in Southern Italy. Immunology 111: 318-322.
24.
Duarte R, Carvalho C, Pereira C, et al. (2011): HLA class II alleles as markers of tuberculosis susceptibility and resistance. Rev Port Pneumol 17: 15-19.
25.
Ryom L, Cotter A, Miguel R, et al. (2020): European AIDS Clinical Society (EACS) guideline. 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0. doi: https://doi.org/10.1111/hiv.12878
26.
Products: TB testing with QFT-Plus (2023): https://www.qiagen.com.
27.
Equipment: DTlite Operation Manual. https://dna-technology.com/dnaproducts/equipments/rtamplificators/dt_lite
28.
Harbage B, Dean AG. (1999): Distribution of Epi Info software: An evaluation using the internet. Am J Prev Med 16: 314-317.
29.
Satapornpong P, Jinda P, Jantararoungtong T, et al. (2020): Genetic diversity of HLA class I and class II alleles in Thai populations: Contribution to genotype-guided therapeutics. Front Pharmacol 11: 78.
30.
Calliope A, Petersen J, Rossjohn J, Fugger L (2018): HLA variation and disease. Nat Rev Immunol 18: 325-339.
31.
Stanevicha V, Eglite J, Sochnevs A, et al. (2003): HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia. Arthritis Res Ther 5: 340-346.
32.
Visnevska M, Stanevica V, Eglite J, et al. (2018): Molecular genetic studies of human leukocyte antigen (HLA) class II alleles and clinical profile of acute rheumatic fever in Latvia. Pediatr Rheumatol 16. doi: https://doi.org/10.1186/s12969-018-0265-6.
33.
Davidsone Z, Eglite J, Lazareva A, et al. (2016): HLA II class alleles in juvenile idiopathic arthritis patients with and without temporomandibular joint arthritis. Pediatr Rheumatol Online J 14: 24.
34.
Volikova O. (2015): Correlation of locus alleles of DRB1 II class of histocompatibility complex with clinical, immunological and virological parameters in HIV infection. Eur Sci Rev 9-10: 48-51.
35.
National Library of Medicine (2020): HLA-DRB1 – major histocompatibility complex, class II, DR beta 1. https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=3123
36.
Sia JK, Rengarajan J (2019): Immunology of Mycobacterium tuberculosis infections. Microbiol Spectr 7: 10.1128/microbiolspec.GPP3-0022-2018.
37.
Kasjko D, Jasinskis V, Eglite J, et al. (2014): Research of HLA II class DRB1, DQA1, DQB1 genetic markers in patients with HIV infection and AIDS. Br J Med Med Res 4: 4482-4500.
38.
MacDonald KS, Fowke K, Kimani J, et al. (2000): Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 181: 1581-1589.
39.
Stephens HAF, Klaythong R, Sirikong M, et al. (2002): HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60: 309-318.
